Researchers examining holographic protein models during a discussion.

Your work is changing the world faster than the world can understand it.

You know where the science is genuinely extraordinary, where the hype outruns the evidence, and which consequences deserve far more public attention. The Genomic Power Shift is an invitation to bring that knowledge into the wider conversation without flattening the science.

If you are tired of seeing your field reduced to miracle cure, Frankenstein panic or startup theatre, I would like to talk.

Because the public story about your field is already being written — by press releases, panic headlines and startup pitch decks — whether or not you are in the room.

What is the value for you?

This is a chance to shape how people outside the field understand the work—and what society does with it.

Make your work legible

Help family, friends, patients and the wider public finally understand what you do, why it is difficult, and why it matters—without reducing years of work to a miracle headline or a tidy metaphor.

Put the consequences on record

Share how you think today’s genomics will change medicine, reproduction, food, biodiversity, security or society. Name the benefits you believe in, the risks you see, and the trade-offs most people are missing.

Reach beyond the field

Bring expert insight into a public conversation intended for policymakers, investors, journalists, clinicians, educators and readers—the people funding, governing, reporting on and living with the consequences of genomic science.

Correct the story early

Public narratives harden quickly. Contributing now is a chance to challenge bad assumptions before genomics is explained mainly through press releases, panic, product claims and science fiction.

What I want to hear from you

What can your field now do that sounded impossible ten years ago?
Where is the public story most detached from the evidence?
Which clinical or scientific advance deserves far more attention?
What risk is being minimised because it is awkward, uncertain or commercially inconvenient?
Which decisions should policymakers understand before the technology scales?
What will this work change for patients, families, species or future generations?
Where does the metaphor of “programmable biology” break down?
What do you wish your own family understood about your work?

The scale is already public-interest science: the 100,000 Genomes Project sequenced participants affected by cancer and rare disease; WHO estimates bacterial AMR directly caused 1.27 million deaths in 2019; and WWF’s 2024 Living Planet Report records an average 73% decline in monitored wildlife populations from 1970 to 2020.

A serious conversation, on your terms

What do you think the rest of us need to understand?

Interviews can be informal, off the record, background-only or fully attributed. You do not need a finished thesis or a polished public position—just work worth discussing and a view of where it may lead.